Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Dividend & Equity Income · Copeland

Copeland Dividend Growth Fund Copeland Dividend Growth Fund Class C shares (CDCRX)

Ticker CDCRX · · Holdings as of May 31, 2026

Expense ratio
1.95%$195/yr per $10k
5-yr return
+8.0%annualized
1-yr return
+7.8%as of Dec 2025
Net assets
$25.8Mall share classes
Holdings
65

Bottom line

Is CDCRX a good fund? The bottom line

CDCRX is a share class of Copeland Dividend Growth Fund, a managed dividend & equity income mutual fund from Copeland.

It charges 1.95% — about $195 a year on every $10,000 invested, more expensive than 97% of dividend & equity income funds we track.

It returned +7.8% over one year, +8.0% a year over five years, +7.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $25.8 million in net assets and 65 holdings, its largest position is Lam Research Corp (2.7%) and the top 10 make up 24.1% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.95%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year
  • Small fund ($25.8 million) — small funds are likelier to close

Updated Nov 19, 2026

What CDCRX invests in

The Fund seeks long-term capital appreciation and income generation.

The Fund seeks to achieve its investment objectives of producing long-term capital appreciation and income generation by purchasing equities of companies with a proven track record of dividend growth. The Fund is primarily composed of common stocks, master limited partnership units (?MLPs?) and equity real estate investment trusts (?REITs?) of U.S. companies or entities that have raised their dividends in the most recent annual period and cash equivalents. The Fund will limit its investment in MLPs to no more than 25% of its net assets. An equity REIT invests the majority of its assets directly in real property and derives its income primarily from rents and from capital gains on real estate appreciation, which are realized through property sales. Under normal market conditions, the Fund invests at least 80% of its net assets (including borrowings for investment purposes) in securities…

From the fund's prospectus (filed Mar 27, 2026).

CDCRX performance

Average annual total returns
1 yr5 yr10 yr
CDCRX+7.8%+8.0%+7.4%
Dividend & Equity Income median+14.6%+10.1%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full CDCRX performance history →

What CDCRX costs

On a $10,000 investment, CDCRX's 1.95% expense ratio costs about $195 a year. The prospectus estimates $2,950 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.

See the full CDCRX fee table →

CDCRX top 10 holdings

#Holding% of fund
1Lam Research Corp2.67%
2Broadcom Inc2.64%
3Apple Inc2.63%
4Morgan Stanley2.45%
5Wesco International Inc2.36%
6Taiwan Semiconductor Manufacturing Company Ltd2.34%
7J.b. Hunt Transport Services Inc2.33%
8Alphabet Inc2.27%
9Microsoft Corp2.25%
10Amphenol Corp2.19%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 24.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to CDCRX

More funds like CDCRX →

CDCRX FAQ

What is the expense ratio of CDCRX?
CDCRX's expense ratio is 1.95%, which works out to about $195 a year for every $10,000 invested. The prospectus estimates total costs of $2,950 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CDCRX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.95%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year; small fund ($25.8 million) — small funds are likelier to close. This is general information, not personalized advice.
What does CDCRX hold?
CDCRX's largest holdings are Lam Research Corp (2.7%), Broadcom Inc (2.6%), Apple Inc (2.6%), Morgan Stanley (2.5%), Wesco International Inc (2.4%). It holds 65 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is CDCRX's 5-year return?
CDCRX returned +8.0% a year over the five years ending Dec 31, 2025, and +7.4% a year over ten years. Past performance does not guarantee future results.
Does CDCRX have a sales load?
No. CDCRX has no front-end sales charge.
Who manages CDCRX?
CDCRX is offered by Copeland through Copeland Trust.